| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.00074 | 1 |